Current views on the pre-pregnancy planning
D.M. Ibragimova, Yu.E. Dobrokhotova
Pirogov Russian National Research Medical University, Moscow, Russian Federation
Pre-pregnancy planning is a complex of preventive measures to minimize the risks associated with the realization of reproductive function. Today, women are characterized by high level of anxiety and depressive disorders which result in the dysfunction of hypothalamus and pituitary gland manifested with physiologically elevated levels of prolactin. Available data demonstrate that even physiologically elevated levels of prolactin (in particular, in prolonged physical and emotional stresses) can lead to infertility. Prolactin is commonly regarded as the “stress hormone” since its production increases in regular chronic stresses. In many women, excessive prolactin secretion occurs in stresses.
This paper addresses this issue as well as clinical experience with vitamin mineral complex containing Vitex agnus-castus extract used for pre-pregnancy planning in women with functional hyperprolactinemia as a result of chronic stress. Reducing micronutrient deficien cy (as a part of pre-pregnancy planning) significantly improves somatic health, cognitive functions, and life expectancy of the future child (level of evidence A). Vitex agnus-castus extract normalizes prolactin levels and menstrual cycle thus helping women get pregnant more often and improving the functions of female reproductive system.
Keywords: pre-pregnancy planning, vitamin mineral complex containing Vitex agnus-castus extract, pregnancy, infertility, hyperprolactinemia, stress.
For citation: Ibragimova D.M., Dobrokhotova Yu.E. Current views on the pre-pregnancy planning. Russian Journal of Woman and Child Health. 2020;3(1):51–54. DOI: 10.32364/2618-8430-2020-3-1-51-54.
The publication is supported by JSC “Aquion” (Russian Federation) according to the internal policies and existing legislation. JSC “Aquion”, its employees or representatives did not participate in the writing of this paper and are not responsible for either content or any financial or other agreements with third parties regarding this paper. Aquion’s view can be different from that of the authors and Editorial Board.
About the authors:
Dzhamilya M. Ibragimova — MD, PhD, Associate Professor of the Department of Obstetrics and Gynecology, ORCID iD 0000-0002-8738-868X;
Yuliya E. Dobrokhotova — MD, PhD, Professor, Head of the Department of Obstetrics and Gynecology, ORCID iD 0000-0002-7830-2290.
Pirogov Russian National Research Medical University. 1, Ostrovityanov str., Moscow, 117997, Russian Federation.
Contact information: Dzhamilya M. Ibragimova, e-mail: firstname.lastname@example.org. Financial Disclosure: no authors have a financial or property interest in any material or method mentioned. There is no conflict of interests. Received 20.10.2019.
2. Wuttke V., Zaydlova-Wuttke D., Yarri G., Artymuk N. The role of the sacred Vitex (Vitex agnus castus) in gynecological endocrinology. Ginekologiya. 2012;1:8–11.
3. Melnichenko G.A., Marova E.I., Dzeranova L.K., Vaks V.V. Hyperprolactinemia in men and women. A manual for doctors. M., 2007 (in Russ.).
4. Dzeranova L.K. Hyperprolactinemia syndrome in women and men: clinic, diagnosis and treatment: thesis. М., 2007 (in Russ.).
5. Ovsyannikova T.V. Differential diagnosis and treatment of infertility with hyperprolactinemia. Ginekologiya. 2014;02:34–37 (in Russ.). DOI: 10.26442/2079-5831_16.2.34-37.
6. Freeman M.E., Kanyicska B., Lerant A. et al. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80:1523–1631. DOI: 10.1152/physrev.2000.80.4.1523.
7. Pregravid training. Clinical protocol. Interdisciplinary Association of Reproductive Medicine Specialists. M., 2016 (in Russ.).
8. Ilyina I. Yu., Dobrokhotova Yu.E., Malikova V.O., Chikisheva A.A. Features pregravid preparation in women with connective tissue dysplasia. Ginekologiya. 2018;5(20):42–45 (in Russ.).
9. Kumar S., Mansel R.E., Hughes L.E. et al. Prediction of response to endocrine therapy in pronounced cyclical mastalgia using dynamic tests of prolactin release. Clin Endocrinol (Oxf). 1985;23:699–704. DOI: 10.1111/j.1365-2265.1985.tb01131.x.
10. Gromova O.A., Torshin I. Yu., Limanova O.A. Pregravid preparation of a couple. The role of synergism of micronutrients. Trudnyj pacient. 2015;08–09:29–37 (in Russ.).
11. Ban Y., Xia T., Jing R. et al. Vitex diterpenoids: structural diversity and pharmacological activity. Cur Pharm Des. 2019. DOI: 10.2174/1381612825666191216151703.
12. Carmichael A.R. Can Vitex Agnus Castus be Used for the Treatment of Mastalgia? What is the Current Evidence? Evid Based Complement Alternat Med. 2008;5(3):247–250. DOI: 10.1093/ecam/nem074.
13. Hu Y., Xin H.L., Zhang Q.Y. et al. Anti-nociceptive and anti-hyperprolactinemia activities of Fructus Viticis and its effective fractions and chemical constituents. Phytomedicine. 2007;14(10):668–674. DOI: 10.1016/j.phymed.2007.01.008.
14. Gromova O.A., Limanova O.A., Torshin I. Yu. A systematic analysis of basic and clinical studies, as a justification for the need for the joint use of estrogen-containing drugs with magnesium and pyridoxine preparations. Akusherstvo, ginekologiya i reprodukciya. 2013;3:35–50 (in Russ.).
15. Zhukov O.B., Evdokimov V.V., Zhukov A.A. et al. Professional medical support for a couple with infertility: a modern approach. Consilium Medicum. 2013;7:38–437 (in Russ.).
This work is licensed under a Creative Commons «Attribution» 4.0 License.